Maximum Doses of Salbutamol in 24 Hours
For acute asthma exacerbations, adults can safely receive up to 240 mg of nebulized salbutamol in 24 hours (10 mg every hour for 24 hours), while children can receive 0.15-0.3 mg/kg every 1-4 hours as needed, with no absolute maximum specified in guidelines. 1
Acute Exacerbation Dosing (Emergency/Hospital Setting)
Adults
Nebulized solution: 2.5-10 mg every 1-4 hours as needed after initial three doses 1
- Initial treatment: 2.5-5 mg every 20 minutes for 3 doses
- Maintenance: 2.5-10 mg every 1-4 hours
- Theoretical 24-hour maximum: If dosed at 10 mg every hour = 240 mg/24 hours
MDI (90 mcg/puff): 4-8 puffs every 1-4 hours as needed after initial treatment 1
- Initial: 4-8 puffs every 20 minutes for 3 doses
- Theoretical 24-hour maximum: 8 puffs × 6 doses (every 4 hours) = 48 puffs = 4.32 mg/24 hours
Children
Nebulized solution: 0.15-0.3 mg/kg every 1-4 hours as needed 1
- Initial treatment: 0.15 mg/kg (minimum 2.5 mg) every 20 minutes for 3 doses
- Maintenance: 0.15-0.3 mg/kg every 1-4 hours
- Example for 20 kg child: 0.3 mg/kg × 6 doses (every 4 hours) = 36 mg/24 hours
MDI: Same as adults (4-8 puffs every 1-4 hours) 1
High-Dose Continuous Nebulization (Severe Cases)
Research demonstrates that high-dose continuous albuterol at 75-150 mg/hour (mean 3.7 mg/kg/hr) for up to 31.7 hours has been used safely in children with status asthmaticus, though this is not standard guideline-recommended dosing 2. This represents potential 24-hour doses of 1,800-3,600 mg, far exceeding conventional dosing but associated with low rates of mechanical ventilation and minimal toxicity.
Outpatient/Maintenance Dosing
Adults
Nebulized solution: 2.5 mg three to four times daily 3
- 24-hour maximum: 10 mg (2.5 mg × 4 doses)
MDI: 2 inhalations (180 mcg) every 4-6 hours 4
- 24-hour maximum: 8-12 inhalations = 0.72-1.08 mg
Children ≥4 years
- MDI: Same as adults 4
Children <15 kg
- Should use 0.5% solution instead of 0.083% for more precise dosing 3
Important Clinical Considerations
Dose-limiting side effects: Tremor is the primary dose-limiting adverse effect with both oral and inhaled routes 5. Cardiovascular effects (tachycardia, decreased diastolic blood pressure) occur but rarely require intervention even at very high doses 2.
Delivery method matters:
- MDI with spacer delivers significantly lower total drug doses (0.10 mg/kg vs 0.81 mg/kg) compared to nebulization while achieving equivalent or superior clinical outcomes 6
- Nebulization is associated with higher incidence of adverse reactions compared to MDI, particularly oxygen dependence in children under 6 years 6, 7
Tolerance development: Children can develop tolerance to salbutamol if used more than once daily, reducing effectiveness 8. If requirements exceed this frequency, add anti-inflammatory therapy rather than increasing salbutamol dose.
Red flags requiring reassessment: If a previously effective dosage regimen fails to provide usual relief, this signals seriously worsening asthma requiring immediate medical evaluation and consideration of corticosteroids, not simply more salbutamol 3, 4.
Practical ceiling: While guidelines specify dosing intervals rather than absolute maximums, the practical upper limit for nebulized therapy in acute settings is approximately 10 mg every hour for adults and 0.3 mg/kg every hour for children, based on the "every 1-4 hours as needed" recommendation 1. Exceeding these doses should only occur in intensive care settings with continuous monitoring.